Medication info
Guardmet Tablet 100/850 mg (Anagliptin, Metformin)

Guardmet Tablet 100/850 mg (Anagliptin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Anagliptin›100mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets (10 tablets/PTP pack × 3), 60 tablets/bottle
Approval status
Active

MFDS item code 201600171 · Approved 2016.01.08 · Insurance code 644914140

Summary

Main use
Improves glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be adjusted according to efficacy and tolerability without exceeding the maximum recommended daily doses of each component: anagliptin 200mg and metformin 2000mg. The initial dose of this medicine should be determined according to the patient's current treatment regimen. To reduce gastrointestinal adverse reactions associated with metformin use, take this medicine twice daily with meals, and increase the dose gradually. Swallow this medicine whole. 1. When adequate glycemic control cannot be achieved with metformin monotherapy The initial dose of this medicine should be determined according to the patient's current treatment regimen and should provide anagliptin 100mg twice daily (total daily dose 200mg) and the patient's existing metformin dose; take 1 tablet of this medicine 100/500mg, 100/850mg, or 100/1000mg twice daily. 2. Replacement of combination therapy with anagliptin and metformin For patients switching to this medicine from combination therapy with anagliptin and metformin, treatment may be started at the existing doses of anagliptin and metformin.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in adults with type 2 diabetes mellitus

  • Poor blood sugar control
View approved original text

This medication is used to assist in blood sugar control for adult patients with type 2 diabetes who need to take anagliptin and metformin together. It is suitable for patients who primarily manage their blood sugar through diet and exercise but have difficulty achieving sufficient blood sugar improvement when taking metformin alone. Additionally, it is used as a substitute when there is a need to change the treatment regimen for patients who have previously been taking anagliptin and metformin together. In this way, it effectively aids in blood sugar management and helps in the treatment of diabetes.

How to take

Adult dose

The dose of this medicine should be adjusted according to efficacy and tolerability without exceeding the maximum recommended daily doses of each component: anagliptin 200mg and metformin 2000mg. The initial dose of this medicine should be determined according to the patient's current treatment regimen. To reduce gastrointestinal adverse reactions associated with metformin use, take this medicine twice daily with meals, and increase the dose gradually. Swallow this medicine whole. 1. When adequate glycemic control cannot be achieved with metformin monotherapy The initial dose of this medicine should be determined according to the patient's current treatment regimen and should provide anagliptin 100mg twice daily (total daily dose 200mg) and the patient's existing metformin dose; take 1 tablet of this medicine 100/500mg, 100/850mg, or 100/1000mg twice daily. 2. Replacement of combination therapy with anagliptin and metformin For patients switching to this medicine from combination therapy with anagliptin and metformin, treatment may be started at the existing doses of anagliptin and metformin.

Precautions

This medication helps in controlling blood sugar levels. However, it can rarely cause a serious condition called lactic acidosis, so caution is required. It should not be administered to patients with poor kidney function, weak heart function, or those with acute infections or severe trauma. Furthermore, patients scheduled for surgery should discontinue this medication 48 hours prior to surgery and can resume only after confirming normal kidney function. This medication may cause symptoms of hypoglycemia when taken with insulin or other diabetes medications, so blood sugar levels should be closely monitored during treatment. If sudden severe abdominal pain or vomiting occurs while taking this medication, it may indicate acute pancreatitis, and immediate consultation with a physician is necessary. Regular monitoring of liver and kidney functions should be conducted during the use of this medication to ensure there are no abnormalities, especially for elderly patients or those with impaired kidney function. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid alcohol while taking this medication. Pregnant or breastfeeding women should not use this medication, and those planning to become pregnant should also avoid it. Some patients may experience side effects such as constipation, diarrhea, dizziness, and headache; if any abnormal symptoms persist, consultation with a medical professional is recommended. Moreover, this medication may lower vitamin B12 levels, so regular blood tests are recommended. In case of overdose, seek medical attention immediately for appropriate treatment. Finally, the safety and efficacy of this medication have not been established in children, so it is advisable not to use it.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • constipation
  • hypoglycemia
  • positive occult blood in stool
  • diarrhea
  • gastritis
  • abdominal distension
  • abdominal pain
  • abdominal discomfort
Show 31 more
  • elevated serum amylase
  • nausea
  • vomiting
  • enteritis
  • bloating
  • peptic ulcer
  • rash
  • itching
  • elevated ALT
  • elevated AST
  • elevated γ-GTP
  • dizziness
  • anemia
  • increased white blood cell count
  • nasopharyngitis
  • edema
  • elevated CK
  • positive blood in urine
  • elevated serum uric acid
  • pharyngitis
  • upper respiratory infection
  • chest pain
  • headache
  • dyspepsia
  • low back pain
  • skeletal pain
  • acute pancreatitis
  • dermatomyositis
  • loss of appetite
  • drowsiness
  • arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container, protected from air and moisture, and kept at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP pack × 3), 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.